Student or educator? Sign up with your school email and get 6 months of Pro free.
Cited by 159

The DOI matches its Crossref record; 26 of the 26 references it cites were found in a registry or an index.

Stanniocalcin 1 is a phagocytosis checkpoint driving tumor immune resistance

Open access
Lin, Heng, Kryczek, Ilona, Li, Shasha, Green, Michael D., Ali, Alicia, Hamasha, Reema, Wei, Shuang, Vatan, Linda, Szeliga, Wojciech, Grove, Sara, Li, Xiong, Li, Jing, Wang, Weichao, Yan, Yijian, Choi, Jae Eun, Li, Gaopeng, Bian, Yingjie, Xu, Ying, Zhou, Jiajia, Yu, Jiali, Xia, Houjun, Wang, Weimin, Alva, Ajjai, Chinnaiyan, Arul M., Cieslik, Marcin, Zou, Weiping·2021·Cancer Cell

Abstract

Summary Immunotherapy induces durable clinical responses in a fraction of patients with cancer. However, therapeutic resistance poses a major challenge to current immunotherapies. Here, we identify that expression of tumor stanniocalcin 1 (STC1) correlates with immunotherapy efficacy and is negatively associated with patient survival across diverse cancer types. Gain- and loss- of-function experiments demonstrate that tumor STC1 supports tumor progression and enables tumor resistance to checkpoint blockade in murine tumor models. Mechanistically, tumor STC1 interacts with calreticulin (CRT), an “eat-me” signal, and minimizes CRT membrane exposure - thereby abrogating membrane CRT-directed phagocytosis by antigen-presenting-cells (APCs), including macrophages and dendritic cells. Consequently, this impairs APC capacity of antigen presentation and T cell activation. Thus, tumor STC1 inhibits APC phagocytosis and contributes to tumor immune evasion and immunotherapy resistance. We suggest that STC1 is a previously unappreciated phagocytosis checkpoint and targeting STC1 and its interaction with CRT may sensitize to cancer immunotherapy.

Overview

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1016/j.ccell.2020.12.023

Cites

26 of 26 references verified0 citation errors · 0 not checkable

Statistics

Verification

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Citations

Cites

Show all 26 references

Cited by

See all 159

Metadata

Authors
Lin, H., Kryczek, I., Li, S., Green, M. D., Ali, A., Hamasha, R., Wei, S., Vatan, L., Szeliga, W., Grove, S., Li, X., Li, J., Wang, W., Yan, Y., Choi, J. E., Li, G., Bian, Y., Xu, Y., Zhou, J., Yu, J., Xia, H., Wang, W., Alva, A., Chinnaiyan, A. M., Cieslik, M., & Zou, W.
Venue
Cancer Cell
Publisher
Elsevier BV
Published
2021-04
Volume
39
Issue
4
Pages
480-493.e6
ISSN
1535-6108 (ISSN-L)
OpenAlex
W3124577436
Cited by
159
References
26
FWCI
8.48
Type
journal article
Language
en
Open access
bronze

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

How to cite

Cite CoChat for the checks on this page, and the paper for its own findings.

This page
CoChat. (2026). Citation check: Stanniocalcin 1 is a phagocytosis checkpoint driving tumor immune resistance. https://app.cochat.ai/papers/10.1016/j.ccell.2020.12.023
The paper
Lin, H., Kryczek, I., Li, S., Green, M. D., Ali, A., Hamasha, R., Wei, S., Vatan, L., Szeliga, W., Grove, S., Li, X., Li, J., Wang, W., Yan, Y., Choi, J. E., Li, G., Bian, Y., Xu, Y., Zhou, J., . . . Zou, W. (2021). Stanniocalcin 1 is a phagocytosis checkpoint driving tumor immune resistance. Cancer Cell. https://doi.org/10.1016/j.ccell.2020.12.023

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.